Applied Genetic Technologies (AGTC) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Applied Genetic Technologies (AGTC) PT Lowered to $18 at Stifel on ACHM-B3 Uncertainty
February 9, 2017 9:28 AM ESTStifel analyst Stephen Wiley reiterates Buy rating, but lowers price target on Applied Genetic Technologies Corp. (NASDAQ: AGTC) to $18 (from $22), noting vague commentary on ACHM-B3 and muted efficacy improvement expectations for XLRS.
Wiley comments, "We expect managements admittedly vague commentary around... More
Applied Genetic Technologies Corp. (AGTC) PT Lowered to $14 at BMO Capital
February 9, 2017 6:40 AM ESTBMO Capital Markets analyst Matthew Luchini reiterates Outperform rating, but lowers price target on Applied Genetics Technologies (NASDAQ: AGTC) to $14 (from $20), citing that XLRS is on track, but ACHM needs more follow-up testing.
Luchini comments, "We are lowering our price target on AGTC to $14... More
